Cystic Fibrosis Foundation
Eric Wong has a M.S. in Biochemistry and Molecular Biology with 25 years of experience in drug discovery. He has contributed to advancing multiple lead compounds into clinical trials including Belumosudil (REZUROCKā¢) and has worked across therapeutic areas including metabolic disorders, cardiovascular diseases, and cystic fibrosis. Currently at the Cystic Fibrosis Foundation Laboratory, his research focuses on nonsense mutation therapeutics.
Friday, October 24, 2025
10:15 AM - 12:15 PM PDT